Sophie E M Kelly - National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 13 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia

Joseph M. Rocco, Kristin L. Boswell,Elizabeth Laidlaw,Brian Epling,Megan Anderson, Leonid Serebryannyy,Sandeep Narpala, Sarah OConnell, Heather Kalish,Sophie Kelly, Sarah Porche, Cihan Oguz,

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): 503-512

Cited0Views0WOSBibtex

Immune response to COVID-19 vaccines in people with immunodeficiencies

Emily Ricotta, Mackenzie Zendt, Fausto Bustos Castillo,Sophie Kelly,Taylor A. Saturday, Maureen DeGrange, Anita Ginigeme, Lurline Wu, Viviane Callier,Ana M Ortega-Villa,Mondreakest Faust, Kara Bugal,

Research Square (Research Square) (2023)

Cited0Views0Bibtex

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment

Brian P. Epling,Joseph M. Rocco,Kristin L. Boswell,Elizabeth Laidlaw,Frances Galindo,Anela Kellogg,Sanchita Das,Allison Roder,Elodie Ghedin,Allie Kreitman,Robin L. Dewar,Sophie E. M. Kelly,

Clin Infect Dis（2023）

Cited19Views0WOSBibtex

Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months

Maria Karkanitsa,Yan Li,Shannon Valenti,Jacquelyn Spathies,Sophie Kelly,Sally Hunsberger, Laura Yee,Jennifer A Croker,Jing Wang,Andrea Lucia Alfonso,Mondreakest Faust,Jennifer Mehalko,

medRxiv : the preprint server for health sciences (2023)

Cited0Views0WOSBibtex

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment

Brian P. Epling,Joseph M. Rocco,Kristin L. Boswell,Elizabeth Laidlaw,Frances Galindo,Anela Kellogg,Sanchita Das,Allison Roder,Elodie Ghedin,Allie Kreitman,Robin L. Dewar,Sophie E. M. Kelly,

CLINICAL INFECTIOUS DISEASESno. 4 (2023): 573-581

Cited0Views0Bibtex

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies

Mackenzie Zendt,Fausto A Bustos Carrillo,Sophie Kelly,Taylor Saturday, Maureen DeGrange, Anita Ginigeme, Lurline Wu, Viviane Callier,Ana Ortega-Villa,Mondreakest Faust, Emma Chang-Rabley, Kara Bugal,

Science advancesno. 41 (2023): eadh3150-eadh3150

Cited0Views0WOSBibtex

Undiagnosed COVID-19 in households with a child with mitochondrial disease

Eliza Gordon-Lipkin,Christopher Steven Marcum,Shannon Kruk,Elizabeth Thompson,Sophie E.M. Kelly,Heather Kalish,Matthew D. Hall,Peter J. McGuire

medRxiv (Cold Spring Harbor Laboratory) (2022)

Cited0Views0Bibtex

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Clarisa M. Buckner,Lela Kardava,Omar El Merhebi,Sandeep R. Narpala,Leonid Serebryannyy,Bob C. Lin,Wei Wang,Xiaozhen Zhang,Felipe Lopes de Assis,Sophie E.M. Kelly,I-Ting Teng,Genevieve E. McCormack,

Cell（2022）

Cited31Views0WOSBibtex

COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir

Brian P. Epling, Joseph M. Rocco, Kristin L. Boswell,Elizabeth Laidlaw,Frances Galindo,Anela Kellogg,Sanchita Das,Allison Roder, Elodie Ghedin,Allie Kreitman,Robin L. Dewar,Sophie E. M. Kelly,

crossref（2022）

Cited0Views0Bibtex

COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir

Brian P Epling,Joseph M Rocco,Kristin L Boswell,Elizabeth Laidlaw,Frances Galindo,Anela Kellogg,Sanchita Das,Allison Roder,Elodie Ghedin,Allie Kreitman,Robin L Dewar,Sophie E M Kelly,

medRxiv : the preprint server for health sciences (2022)

Cited6Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn